---
title: "Hansoh Pharma falls nearly 5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306201516.md"
description: "Hansoh Pharma fell 4.50% to HK$30.96. Down 10.17% over five sessions and down 13.13% YTD."
datetime: "2026-11-20T01:51:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306201516.md)
  - [en](https://longbridge.com/en/news/306201516.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306201516.md)
generator: "portal-rs"
---

# Hansoh Pharma falls nearly 5%

Hansoh Pharma (3692.HK) fell nearly **5%** in Hong Kong trading, last at **HK$30.96**.

The stock is down 10.17% over the past five sessions and down 13.13% year to date. It sits 29.20% below its 52-week high of HK$43.73. Volume was 2.14 times its average.

The Hang Seng Index is down 4.83% over the past five sessions and down 12.23% year to date.

The pharmaceuticals industry index fell 3.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [03692.HK](https://longbridge.com/en/quote/03692.HK.md)

## Related News & Research

- [Hansoh Adds Three Innovative-Medicine Indications to 2026 NRDL](https://longbridge.com/en/news/305581132.md)
- [Hansoh's Aumolertinib Wins EMA Panel Backing for EU Marketing Authorization](https://longbridge.com/en/news/305569307.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)
- [Hansoh Pharmaceutical Group Company Limited (3692) Receives a Buy from Goldman Sachs](https://longbridge.com/en/news/302442690.md)
- [Kuaishou Technology: Q3 loss and weaker revenue meet intensifying competition and costly AI investment](https://longbridge.com/en/news/306088382.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**